Patient Experiences and Reported Outcomes with Dapoxetine

Food and Drug Administration approval.

Are desensitising sprays and creams effective for premature ejaculation?

Here is something for the first time that we have that works,” said Dr. Jon Pryor, chairman of the Department of Urologic Surgery at the University of Minnesota, who led the study.He said the drug worked quickly and with few side-effects. You can take it one to three hours before intercourse,” Pryor said in a telephone interview.The drug is being co-developed by Mountain View, California-based Alza Corp. and Johnson & Johnson Pharmaceutical Services LLC. Ortho Pharmaceutical will market the drug in the United States if it receives U.S. All three companies are units of Johnson & Johnson. Boost your research with our translational medicine data. Boost your decision using our deal data. Boost your research with our Core Patent data.

Identify the latest clinical trials across global registries. Accelerate your research with the latest regulatory approval information. Understand key drug designations in just a few clicks with Synapse.

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals. Synapse data dapoxetine 30mg tablet is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence. GENERIC NAME OF THE MEDICINAL PRODUCT:Dapoxetine HCl Tablets 30mgDapoxetine HCl Tablets 60mgDapoxetine HCl Tablets 90mg QUALITATIVE AND QUANTITATIVE COMPOSITION:A. Dapoxetine HCl Tablets 60mgEach Film Coated Tablet Contains:Dapoxetine Hydrochlorideeq.

What is premature ejaculation and is it common?

A systematic search was performed in PubMed, PEDro, Cochrane, Web of Science, CINAHL, and Academic Search Ultimate databases from inception to October 2024 to identify randomized controlled trials (RCTs). The primary outcome was the intravaginal ejaculatory latency time (IELT), while secondary outcomes were self-perception improvements, assessed using the Premature Ejaculation Diagnostic Tool (PEDT), the premature ejaculation profile (PEP), and other evaluation instruments. Eight RCTs (n = 656 participants) were included. Pooled analysis of studies showed a significant effect of dapoxetine combined with non-pharmacological therapies in improving IELT compared to dapoxetine monotherapy (SDM = 1.6; 95%CI, 0.5-2.8; P = .01), PEDT scores (SDM = 0.9; 95%CI, 0.4-1.4; P < .001) and PEP subscales, with moderate certainty of evidence according to the GRADE guidelines. The non-pharmacological therapies included shockwave therapy, biofeedback, electric stimulation, pelvic floor muscle training, desensitization techniques, psychotherapy, and behavioral therapy.

3.1 Indication

This systematic review and meta-analysis indicate that while dapoxetine is recognized for its beneficial effects, its clinical efficacy is significantly enhanced when combined with non-pharmacological interventions. Combination tab dapoxetine 30 mg therapy increases IELT, reduces PEDT scores, and improves PEP scores. These findings suggest that combination therapy is more effective than dapoxetine monotherapy in improving functional outcomes and self-perception in patients with LPE, supported by moderate certainty of evidence. The first drug formulated to treat premature ejaculation delays climax and also increases reported satisfaction, researchers said on Monday.The drug, called dapoxetine, helped men delay their orgasms significantly and doubled the numbers of men and their female partners reporting “good” sexual satisfaction, they told a conference. "Premature ejaculation is a really common problem, affecting between 10 and 30 percent of all men. Q.S.Approved colours used.THERAPEUTIC INDICATIONS:It is used to treat premature ejaculation in adult men by increasing the time to ejaculate and improves control over ejaculation. This helps to relieve the anxiety or frustration about fast ejaculation.

Tên thương mại

Differentially expressed metabolites were identified, and pathway enrichment analyses were conducted using Small Molecule Pathway Database and Kyoto Encyclopedia of Genes and Genomes. Three machine learning algorithms—Support Vector Machine, Random Forest, and Least Absolute Shrinkage and Selection Operator regression—were employed to screen biomarkers. Subsequently, targeted metabolomics analysis was used to quantify neurotransmitter levels. The primary outcomes included the Premature Ejaculation Diagnostic Tool, the intravaginal ejaculation latency time, and the Clinical Global Impression of Change scale score after a 4-week observation period of on-demand dapoxetine treatment. Multivariate analysis revealed clear separations in metabolic profiles between the PPE and HC groups, and between dapoxetine treatment (DT)-Response and DT-No response groups.

Tương tác

Pathway analysis indicated significant enrichment in amino acid metabolism pathways for PPE-related differentially expressed metabolites (DEMs). Additionally, DT-Response-related DEMs were associated with D-Amino acid metabolism and Arginine biosynthesis. Machine learning identified a panel of 4 consensus metabolites for diagnosing PPE, achieving an area under the curve (AUC) of 0.995 in the train cohort and 0.917 in the test cohort. For predicting DT response, three metabolites were selected, forming a model with an AUC of 0.905 (train) and 0.811 (test). It is important to note that these promising initial results require further validation in larger, independent cohorts to confirm their generalizability.

Mechanism of action

Furthermore, targeted metabolomics analysis confirmed significant dysregulation of multiple neurotransmitters in the PPE group. The machine learning-based models we established show robust performance in diagnostic and dapoxetine treatment response prediction. The establishment of the machine learning-based diagnostic and predictive models represents a key strength, though their clinical translation requires further validation in larger cohorts. This study delineates distinct metabolic profiles in PPE, establishes robust machine learning-based models for diagnosis and DT-Response prediction, and reveals the involvement of neurotransmitter dysregulation in its pathophysiology. 01 Feb 2026·JOURNAL OF CLINICAL PHARMACOLOGY Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects Author: Wu, Tong ; Wang, Yiming ; Qiu, Wen ; Bai, Fuqiang ; Lu, Haobo ; Pu, Libin ; Gao, Yuan Dapoxetine is a short‐acting selective serotonin reuptake inhibitor used to treat premature ejaculation. CAUTION & WARNING:Keep medicine out of reach of children.May be injurious if taken in large dosage for a long time.Do not exceed the recommended dose (1 Tablet only) without consulting a physician. STORAGE & DOSAGE:STORAGE: Keep in a cool and dry place away from light.DOSAGE: As directed by the Physician.

• Prescription only in most countries; requires medical evaluation before initiation.
• A baseline assessment of blood pressure and cardiovascular risk is recommended.
• Regular follow-up every 3-6 months to monitor efficacy and side effect profile.

Dapoxetine, a new antidepressant, has been found to be safe and effective for the treatment of premature ejaculation, according to two major clinical trials.

GPhC Regulated Pharmacy

However, its clinical effectiveness is challenged by substantial inter‐individual variability in pharmacokinetics, as both the drug's therapeutic efficacy and the incidence of adverse reactions are highly dependent on its exposure. This study aims to develop a population pharmacokinetic model for dapoxetine, to investigate the sources of the variability, and to identify demographic and pharmacogenetic factors that influence drug exposure. The pharmacokinetic data for this analysis were obtained from a bioequivalence study conducted in 39 healthy Chinese male subjects. As part of this study, all volunteers were genotyped for the CYP3A4*1G, CYP3A5*3, CYP2D6*10, and CYP2D6*41 allelic variants. Population pharmacokinetic modeling was performed in Monolix.

Product Image

The final model was then used to simulate and compare the effect of different covariate levels on dapoxetine exposure. A two‐compartment model with first‐order absorption and an absorption lag time best described the pharmacokinetics of dapoxetine. The population parameters for apparent clearance (CL/F), apparent intercompartmental clearance (Q/F), apparent central volume of distribution (Vc/F), apparent peripheral volume of distribution (Vp/F), absorption lag time (Tlag), and absorption rate constant (ka) were 37.8 L/h, 17.2 L/h, 65.6 L, 191.7 L, 0.68 h, and 1.29/h, respectively. CYP2D6*10 and CYP2D6*41 alleles were found to be significant covariates on CL/F. The CYP3A4*1G allele influenced Q/F, while body mass index (BMI) was a significant covariate on Vc/F.

Brand Names

Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to dapoxetine spain inter‐individual variability and influencing drug exposure. 02 Nov 2025·Journal of Sexual Medicine Dapoxetine combined with non-pharmacological approaches for lifelong premature ejaculation. Author: Avendaño-Coy, Juan ; Nieves Martín, Marta ; Marín Novoa, Patricia Recent research has highlighted the potential advantages of combining pharmacologic and non-pharmacologic approaches in treating lifelong premature ejaculation (LPE). Individual therapies have demonstrated efficacy but there is a lack of comprehensive analysis comparing combined treatments to pharmacologic monotherapy. To assess the combined effect of dapoxetine with non-pharmacological therapies compared to drug monotherapy in improving ejaculatory latency, functionality, and self-perception of sexual dysfunction in individuals with LPE. Dapoxetin is a short-acting selective serotonin reuptake inhibitor (SSRI). It is not uncommon for SSRIs to be used off-label for premature ejaculation.

• In Japan, dapoxetine 60 mg was approved in 2021, marketed under brand names like Priligy.
• Other brands include Joy-Pox, Dapex, and Duralast; generic versions available in some regions.
• Ensure genuine product from licensed pharmacies to avoid counterfeit tablets.

Experts doubt it will be approved by the FDA shortly because SSRIs come with undesirable side-effects after long-term use, such as psychiatric problems, dermatological reactions, increase in body weight, lower sex-drive, nausea, headache, upset stomach and weakness. Dr. Jon Pryor, head researcher, University of Minnesota, said that Dapoxetine lengthened ejaculation time and also gave patients more control over ejaculation. You can read about this in the journal The Lancet. The research team examined the results of two trials, totalling 2,614 men.